Log in to save to my catalogue

Phase 1 study of safety and preliminary efficacy of intranasal transplantation of human neural stem...

Phase 1 study of safety and preliminary efficacy of intranasal transplantation of human neural stem...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3052639140

Phase 1 study of safety and preliminary efficacy of intranasal transplantation of human neural stem cells (ANGE-S003) in Parkinson’s disease

About this item

Full title

Phase 1 study of safety and preliminary efficacy of intranasal transplantation of human neural stem cells (ANGE-S003) in Parkinson’s disease

Publisher

England: BMJ Publishing Group Ltd

Journal title

Journal of neurology, neurosurgery and psychiatry, 2024-12, Vol.95 (12), p.1102-1111

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

BackgroundIntranasal transplantation of ANGE-S003 human neural stem cells showed therapeutic effects and were safe in preclinical models of Parkinson’s disease (PD). We investigated the safety and tolerability of this treatment in patients with PD and whether these effects would be apparent in a clinical trial.MethodsThis was a 12-month, single-cen...

Alternative Titles

Full title

Phase 1 study of safety and preliminary efficacy of intranasal transplantation of human neural stem cells (ANGE-S003) in Parkinson’s disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_3052639140

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3052639140

Other Identifiers

ISSN

0022-3050,1468-330X

E-ISSN

1468-330X

DOI

10.1136/jnnp-2023-332921

How to access this item